- Home
- PML vs SIGA Comparison
PML vs SIGA Comparison
Compare PML & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$6.71
Company Overview
Basic Information| Metric | PML | SIGA |
|---|---|---|
| Founded | 2002 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.0M | 486.2M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | PML | SIGA |
|---|---|---|
| Price | $7.81 | $6.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 364.5K | 322.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 5.65% | ★ 8.94% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $132.36 |
| P/E Ratio | ★ N/A | $16.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.10 | $4.95 |
| 52 Week High | $8.67 | $9.62 |
Technical Indicators
Market Signals| Indicator | PML | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 61.67 | 52.95 |
| Support Level | $7.70 | $6.47 |
| Resistance Level | $7.88 | $7.00 |
| Average True Range (ATR) | 0.05 | 0.24 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 60.00 | 51.79 |
Price Performance
Historical Comparison PML
SIGA
About PML Pimco Municipal Income Fund II of Beneficial Interest
PIMCO Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as education, healthcare, and others.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.